Time to Acute Treatment in Intracerebral Hemorrhage Lags Significantly Behind Ischemic Stroke: A Multicenter, Observational Retrospective Study
Authors:
- Kara R. MelmedKara R. Melmed
- Abhijit V. LeleAbhijit V. Lele
- Maranatha AyodeleMAMaranatha Ayodele
- Joshua N. GoldsteinJoshua N. Goldstein
- Aaron LacKampAaron LacKamp
- Keith E. DombrowskiKDKeith E. Dombrowski
- Ayham AlkhachroumAyham Alkhachroum
- Shraddha MainaliShraddha Mainali
- Adam de HavenonAdam de Havenon
- Prashanth KrishnamohanPKPrashanth Krishnamohan
- Christoph StretzChristoph Stretz
- 1 November 2025
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (11) , 3268-3279
Abstract
BACKGROUND: Time-to-treatment goals for acute ischemic stroke (AIS) have substantially improved outcomes, yet similar metrics have not been studied in patients with intracerebral hemorrhage (ICH), where mortality rates are much higher. METHODS: Multicenter, observational retrospective study of patients with ICH and AIS between January 1, 2017, and December 31, 2022, in 11 comprehensive stroke centers across the United States participating in Get With The Guidelines. We included patients with ICH who received antihypertensive therapy and anticoagulation reversal, and patients with AIS requiring intravenous thrombolytic and mechanical thrombectomy. The coprimary outcomes included (1) time-to-treatment and (2) the percentage of patients meeting current national time interval goals. Multivariable logistic regression models controlling for age, sex, race and ethnicity, time to arrival, National Institutes of Health Stroke Scale score, arrival systolic blood pressure, and admission international normalized ratio were constructed to assess the likelihood of patients with ICH being treated within goal compared with patients with AIS. Multivariable logistic regression models were constructed to assess the impact of treatment time on mortality or discharge disposition in patients with ICH. RESULTS: A total of 28 180 patients were identified, of which 7003 patients were included: n=1972 ICH (mean age, 67; 43% female) and n=5031 AIS (mean age, 69; 49% female). The median door-to-first medication was 52 (28–157) minutes for patients with ICH and 42 (30–63) minutes for patients with AIS ( P P P P P 60 minutes. CONCLUSIONS: Time-to-treatment for patients with ICH is significantly longer than for patients with AIS. Faster antihypertensive treatment times are associated with better discharge outcomes in patients with ICH.Keywords
This publication has 29 references indexed in Scilit:
- Emergency Priorities in the Treatment of Cerebral HemorrhageNeurologic Clinics, 2024
- Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019JAMA Neurology, 2024
- Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral HemorrhageAnnals of Neurology, 2020
- Early Stroke Recognition and Time-based Emergency Care Performance Metrics for Intracerebral HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2020
- Worldwide Organization of Neurocritical Care: Results from the PRINCE Study Part 1Neurocritical Care, 2019
- Standards for Neurologic Critical Care Units: A Statement for Healthcare Professionals from The Neurocritical Care SocietyNeurocritical Care, 2018
- Guideline for Reversal of Antithrombotics in Intracranial HemorrhageNeurocritical Care, 2015
- Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral HemorrhageJAMA, 2015
- The Epidemiology of Intracerebral Hemorrhage in the United States from 1979 to 2008Neurocritical Care, 2012
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008